PIZZIGALLO, Eligio
 Distribuzione geografica
Continente #
EU - Europa 4.039
NA - Nord America 3.950
AS - Asia 2.411
Continente sconosciuto - Info sul continente non disponibili 10
AF - Africa 6
SA - Sud America 5
OC - Oceania 2
Totale 10.423
Nazione #
US - Stati Uniti d'America 3.927
CN - Cina 954
UA - Ucraina 940
IE - Irlanda 687
SG - Singapore 684
GB - Regno Unito 603
TR - Turchia 602
FR - Francia 415
SE - Svezia 408
DE - Germania 306
IT - Italia 306
FI - Finlandia 183
IN - India 147
RU - Federazione Russa 129
CA - Canada 20
CZ - Repubblica Ceca 18
BE - Belgio 11
EU - Europa 10
PL - Polonia 10
IL - Israele 8
VN - Vietnam 7
GR - Grecia 6
IR - Iran 5
AT - Austria 3
CH - Svizzera 3
ES - Italia 3
MX - Messico 3
SC - Seychelles 3
AR - Argentina 2
BG - Bulgaria 2
EG - Egitto 2
NL - Olanda 2
AU - Australia 1
AZ - Azerbaigian 1
BR - Brasile 1
CL - Cile 1
CO - Colombia 1
DK - Danimarca 1
HU - Ungheria 1
KR - Corea 1
LT - Lituania 1
MA - Marocco 1
MO - Macao, regione amministrativa speciale della Cina 1
NZ - Nuova Zelanda 1
RO - Romania 1
SA - Arabia Saudita 1
Totale 10.423
Città #
Jacksonville 1.033
Dublin 686
Singapore 605
Chandler 580
Southend 557
Princeton 351
Izmir 340
Nanjing 321
Wilmington 191
Cambridge 171
Santa Clara 135
Beijing 121
Nanchang 119
Dearborn 114
Altamura 99
Ann Arbor 76
Boardman 62
Ashburn 58
Kunming 58
Woodbridge 57
Shenyang 54
Grevenbroich 52
Moscow 49
Tianjin 42
Hebei 41
Jiaxing 35
Los Angeles 27
Pune 27
Changsha 26
Norwalk 26
Hangzhou 24
Chieti 22
Lanzhou 21
Houston 20
Augusta 18
Brno 18
San Mateo 18
Toronto 18
Helsinki 14
Rome 13
Andover 12
Jinan 12
Brussels 11
Changchun 11
Munich 11
Orange 9
Radomsko 9
Dong Ket 7
Falls Church 7
Leawood 7
Ningbo 7
Auburn Hills 6
Guangzhou 6
New York 6
Washington 6
Düsseldorf 5
Haikou 5
Milan 5
Rufina 5
Sant'onofrio 5
Seattle 5
Shanghai 5
Simi Valley 5
Cedar Knolls 4
Kocaeli 4
London 4
Monmouth Junction 4
Pescara 4
Pisa 4
Zhengzhou 4
Ardabil 3
Civitavecchia 3
Edinburgh 3
Grafing 3
Madrid 3
Mexico City 3
Mileto 3
Mumbai 3
Noto 3
Nuremberg 3
Taizhou 3
Venafro 3
Vienna 3
Walnut 3
Bangalore 2
Bari 2
Berazategui 2
Cairo 2
Forest City 2
Fuzhou 2
Hanover 2
Hefei 2
Kirkland 2
Quzhou 2
Romola 2
San Benedetto del Tronto 2
Sofia 2
Tappahannock 2
Torino 2
Afragola 1
Totale 6.567
Nome #
Caso clinico di endoplastite da Staphylococcus capitis. 142
La sindrome di Waterhouse-Friderichsen quale complicanza fatale nel bambino febbrile: descrizione di due casi clinici. 112
HPV e displasie della cervice uterina: ricerca dell'HPV-DNA con PCR e correlazioni con l'esame citologico, colposcopico e istobioptico 108
Ricerche sull'autoimmunità in alcune epatopatie. 107
Differential expression of interferon-induced microRNAs in patients with chronic hepatitis C virus infection treated with pegylated interferon alpha 105
Valutazione della sindrome da fatica cronica mediante A.B.R.: risultati preliminari 103
Cytokine patterns correlate with liver damage in patients with chronic hepatitis B and C. 100
Metabolic modifications in HIV-infected women 98
Ricerca con PCR e genotipizzazione dell'HPVDNA in donne con dispiasia della cervice uterina e nei loro partner 97
Autoimmunità nelle epatiti croniche in terapia con IFN-alfa 95
Association between plasma interleukin-18 levels and liver injury in chronic hepatitis C-virus infection and non-alcoholic fatty liver disease. 94
Cytomegalovirus infection in heart-transplants recipients, in a central region of Italy 94
Alterations in muscles of CFS patients at morphological. biochemical and molecular level. 91
Interleukin-4 and interferon-gamma production during HIV-1 infection and changes induced by antiretroviral therapy. 91
I potenziali evocati uditivi troncoencefalici nella valutazione della Sindrome da Fatica Cronica. 90
Specific oxidative alterations in vastus lateralis muscle of patients with the diagnosis of chronic fatigue syndrome. 89
Could S-100b be a marker of the neurologic involvement in HIV-affected patients? 85
Efficacia clinica del trattamento intravescicale con BCG per neoplasie vescicali superficiali in rapporto alla risposta immunitaria indotta. 84
Treatment with silibyn- Vitamin E- Phospholipid complex in patients with Hepatitis C infection. 83
Ocular manifestations in chronic fatigue syndrome. 83
Prognostic Value of the Fibrosis-4 Index in Human Immunodeficiency Virus Type-1 Infected Patients Initiating Antiretroviral Therapy with or without Hepatitis C Virus 83
Circadian variations of prolactine (PRL), thyreotropic hormone (TSH), adrenocorticotropic hormone (ACTH) and cortisol (CS) in the chronic fatigue syndrome (CFS). 82
Quality of life, depression and cytokine patterns in patients with chronic hepatitis C treated with antiviral therapy. 82
Associations between hypertriglyceridemia and serum ghrelin, adiponectin, and IL-18 levels in HIV-infected patients. 82
Usefulness of Leifson staining method in diagnosis of Helicobacter pylori infection. 82
Psychiatric diagnosis and comorbidity and chronic fatigue syndrome 81
Valutazione comparativa delle tecniche di immunodiffusione su agar e counter-elettroforesi nella ricerca dell'antigene Australia. 81
Multicentre study on the prevalence of symptoms and symptomatic treatment in HIV infection. 80
Acute urinary retention due to HSV-1: a case report 80
Cystatin C, adipokines and cardiovascular risk in HIV infected patients. 80
Peripheral blood mononuclear cell beta-endorphin concentration is decreased in chronic fatigue syndrome and fibromyalgia but not in depression: preliminary report 80
Inguinal lymphadenopathy due to Bartonella henselae 79
Economic evaluation on HIV treatments: The I.Co.N.A. cohort study. 79
Is moderate HIV-viremia associated with a higher risk of clinical progression in HIV-infected people treated with high active antiretroviral therapy. 79
Acquired immunodeficiency without HIV infection: epidemiology and clinical autcome in Italy. 78
Hepatitis C virus infection and myositis: a virus localization study. 78
A leukemic patient with hepatosplenic abscesses due to coagulase-negative staphylococci. 77
Use of epoetin beta during combination therapy of infection with hepatitis c virus with ribavirin improves a sustained viral response. 77
Neurite acistica bilaterale HIV-correlata: descrizione di un caso ad evoluzione favorevole in seguito a terapia antiretrovirale. 76
Interruption of highly active antiretroviral therpy in HIV clinical practice. 76
Proteinuria in an African HIV-infected patient: effects of telmisartan. 76
Vertical transmission of hepatitis C virus: an epidemiological study on 2,980 pregnant women in Italy. 76
An unusual complication of brucellosis: hepatic abscess. 73
Chronic fatigue syndrome: circadian rhythm and hypothalamic-pituitary-adrenal (HPA) axis impairment. 73
The association of chronic hepatitis B and myopathy 73
Effetti del trattamento con vitamina e sulla sintomatologia muscoloscheletrica soggettiva ed oggettiva della sindrome da fatica cronica 73
Methicillin-resistant staphylococcus epidermidis (MRSE) endocarditis treated with linezolid 72
Evolution of HVR-1 quasispecies after 1-year treatment in HIV/HCV-coinfected patients according to the pattern of response to highly active antiretroviral therapy. 72
Improved metabolic profile after switch to darunavir/ritonavir in HIV positive patients previously on protease inhibitor therapy. 72
Patient-reported and Physician-estimated Adherence to HAART. 72
Increased production of oncostatin-M by lymphomononuclear cells from HIV-1-infected patients with neuroAIDS. 71
Sensory characterization of somatic parietal tissues in humans with chronic fatigue syndrome 70
High dose of erythropoietin in management of interferon/ribavirin induced anemia 70
Short communication: Proangiogenic hematopoietic cells in acute HIV infection 70
Insights the reasons for discontinuation of the first highly active antiretroviral therapy (HAART) regimen in a cohort of antiretroviral naive patients 69
Clinical and Pathogenetical Characterization of 238 Patients of a Chronic Fatigue Syndrome Italian Center 68
Involvement of novel human immunodeficiency virus type 1 reverse transcriptase mutations in the regulation of resistance to nucleoside inhibitors. 68
Psychophysical distress and alexithymic traits in chronic fatigue syndrome with and without comorbid depression 68
Nuovi aspetti della terapia antibiotica associata (rassegna critica e contributo personale). 68
Ulteriori osservazioni sul sistema HBeAg-HBeAb in corso di epatite ed in portatori di HBsAg. 68
Ricerca dell'anticorpo contro il virus A (=HAAb) per l'epidemiologia e la diagnosi dell'epatite A. 68
Metabolic syndrome and cardiovascular risk in HIV-infected patients with lipodystrophy. 67
Viral interference between hepatitis B, C and D viruses in dual and triple infections in HIV-positive patients. 67
Mortality from HIV and TB coinfections in higher in Eastern Europe than in Western Europe and Argentina. 67
MR imaging in the clinical diagnosis of chronic fatigue syndrome (CFS). 67
Study of immune alterations in patients with Chronic Fatigue Syndrome to reach a better nosografic and pathogenetic characterization of subgroups with different etiologies. 66
Attualità sulle infezioni batteriche del SNC. 66
The impact of rufloxacin given as prophylaxis to patients with cancer on their oral and faecal microflora. 66
Predictability of sustained virological response to pegylate interferon alpha-2b plus ribavirin therapy by week-8 viral response in HIV-positive patients with chronic hepatitis C infection. 66
Antiretroviral therapy in HIV-infected individuals in clinical practice: are the criteria for initiating and choosing the type of drug regimen based only on immunologic and virologic values? 66
Increased risk of virologic failure to the first antiretroviral regimen in HIV-infected migrants compared to natives: Data from the ICONA cohort 66
Chronic fatigue syndrome following a toxic exposure. 65
Granulomatous cheilitis in an HIV positive patient on HAART Therapy. 65
Comparative analysis of two systems for HCV genotyping. 64
Le associazioni di antibiotici: aspetti clinici. 64
Adherence to highly active antiretroviral therapy is better in patients receiving non-nucleoside reverse transcriptase inhibitor-containing regimens than in those receiving protease inhibitor-containing. 64
b-endorphin concentrations are decreased in peripheral blood mononuclear cells of chronic fatigue syndrome patients: comparison with depression. 64
Use of hematopoietic growth factor in the management of hematological side effects associated to antiviral treatment for HCV hepatitis. 63
Antibodies to hepatitis A virus in Italian patients with chronic liver disease 62
Response to HAART and GB virus type C coinfection in a cohort of antiretroviral-naive HIV-infected individuals. 62
Research on a new hepatitis B antigen-antibody system: e- anti-e. 62
Inflammatory cytokines and S-100b protein in patients with hepatitis C infection and cryoglobulinemias 61
Ricerca degli anticorpi fissanti il complemento contro il virus dell'herpes simplex (ed altri virus neurotropi) in pazienti con sclerosi multipla. 61
Genetic polymorphisms differently influencing the emergence of atrophy and far accumulation in HIV-related lipodystrophy. 61
Ricerche su donatori di sangue Au-positivi: stimolazione in vitro dei linfociti con PHA. 60
L'immunità cellulare nelle epatopatie: stimolazione in vitro dei linfociti con antigeni epatici. 59
Chromatographic and electrophoretic studies of immune complexes in non-A, non-B hepatitis. 59
Risk of developing specific AIDS-defining illness in patients coinfected with HIV and hepatitis C virus with or without cirrhosis. 58
Relationship between musculoskeletal symptoms and blood markers of oxidative stress in patients with chronic fatigue syndrome 58
Impact of social determinants on antiretroviral therapy access and outcomes entering the era of universal treatment for people living with HIV in Italy 58
Occurence of bacteriemia in hematological patients. 57
Determinazione dell'antigene Australia con il metodo radioimmunologico in corso di epatite virale. 57
Submaximal aerobic exercise with mechanical vibrations improves the functional status of patients with Chronic Fatigue Sindrome. 56
Cardiovascular disease risk factors in HIV patients-association with antiretroviral therapy. Results from the DAD study. 56
Predictors of trend in CD4-positive T-cell count and mortality among HIV-1-infected individuals with virological failure to all three antiretroviral-drug classes 54
Behavioral correlates of adherence to antiretroviral therapy. 54
Prognostic factors of early fatal outcome and long-term survival in patients with pneumocistis carinii pneumonia and acquired immunodeficiency syndrome. 52
Virologic and immunologic response to regimens containing nevirapine or efavirenz in combination with 2 nucleoside analogues in the Italian Cohort Naive Antiretrovirals (I. CO.N.A.) Study. 52
Low frequency of severe hepatotoxicity and association with HCV coinfection in HIV-positive patients treated with HAART. 51
Role of hepatitis C virus (HCV) viremia and HCV genotype in the immune recovery from highly active antiretroviral therapy in cohort of antiretroviral-naive HIV-infected individuals. 51
Totale 7.407
Categoria #
all - tutte 41.437
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 41.437


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020775 0 0 0 0 0 0 211 196 28 105 223 12
2020/2021991 185 9 185 4 88 197 8 6 83 179 12 35
2021/2022597 7 3 5 103 47 12 11 68 52 13 85 191
2022/20231.921 206 271 112 187 178 404 136 112 226 18 27 44
2023/2024708 58 27 34 18 33 205 238 19 0 6 5 65
2024/20251.365 216 579 468 33 21 48 0 0 0 0 0 0
Totale 10.649